Off-hours admission to pediatric intensive care and mortality

Michael C McCrory1, Emily W Gower2, Sean L Simpson3

  • 1Departments of Anesthesiology, Section on Pediatric Critical Care Medicine, mmccrory@wakehealth.edu.

Pediatrics
|October 8, 2014
PubMed

Insights

Off-hours admission to pediatric intensive care units (PICUs) does not increase patient mortality. However, morning admissions (6-11 am) are linked to a higher risk of death, requiring further study in critically ill children.

Area of Science:

  • Pediatric critical care medicine
  • Healthcare quality and safety
  • Epidemiology of critical illness

Background:

  • Critically ill children require pediatric intensive care unit (PICU) admission regardless of time.
  • Staffing and resources may fluctuate based on day or time.
  • Investigating off-hours admission impact on mortality is crucial for PICU care.

Purpose of the Study:

  • To determine if admission during off-hours (nights and weekends) is an independent risk factor for mortality in pediatric intensive care units.
  • To analyze the association between admission timing and patient outcomes in PICUs.

Main Methods:

  • Retrospective cohort study using the Virtual PICU Systems database.
  • Inclusion of patients under 18 years old admitted to PICUs.
  • Mixed-effects multivariable regression analysis adjusted for severity of illness using the Pediatric Index of Mortality 2 (PIM2).

Main Results:

  • Analysis of 234,192 admissions across 99 PICUs (Jan 2009-Sep 2012).
  • Off-hours admissions were less elective and had higher observed ICU mortality (2.7% vs. 2.2%).
  • Multivariable analysis showed off-hours admission was associated with lower odds of mortality (OR 0.91).
  • Morning admissions (6:00 am - 10:59 am) were independently associated with increased death risk (OR 1.27).

Conclusions:

  • Admission during off-hours is not an independent predictor of increased mortality in the pediatric intensive care unit.
  • Morning admission (6:00 am to 10:59 am) is associated with a higher risk of death in PICU patients.
  • Further research is warranted to understand the increased risk associated with morning admissions in PICUs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
542
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
998
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
924
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.7K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
730